| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXEL | Common Stock | Options Exercise | $551,103 | +29,314 | +3.8% | $18.80 | 808,921 | 24 Feb 2025 | Direct | F1 |
| transaction | EXEL | Common Stock | Sale | $1,059,408 | -29,314 | -3.6% | $36.14 | 779,607 | 24 Feb 2025 | Direct | F1, F2 |
| holding | EXEL | Common Stock | 2,723 | 24 Feb 2025 | By 401(k) | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXEL | Option (right to buy) | Options Exercise | $0 | -29,314 | -23% | $0.000000 | 100,000 | 24 Feb 2025 | Common Stock | 29,314 | $18.80 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Includes 266,700 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. |
| F2 | Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.11 to $36.21. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. |
| F3 | Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 24, 2025. |
| F4 | The option, representing the right to purchase a total of 129,314 shares of Common Stock, became fully exercisable on September 10, 2022. |